• Home
  • Technology
  • Gaming
  • Entertainment
  • World & Business
  • Science
  • Sports
  • AI
HomeTechnologyGamingEntertainmentWorld & BusinessScienceSportsAI
World & Business
Report

Johnson & Johnson hikes earnings guidance as pharma growth masks a MedTech stumble

Barron's reports that growth in Johnson & Johnson's pharmaceutical business masked a stumble in MedTech.

Barron'sBA
CNBCCN
BloombergBL
3 Sources, 2h ago, first seen 2h ago

TLDR

Barron's reports that Johnson & Johnson raised its earnings guidance, while growth in its pharmaceutical business masked a stumble in MedTech.

Combined views

—

3 Sources, first seen 2h ago

— likes— comments— saves— reposts

Combined views

—

3 Sources, first seen 2h ago

— likes— comments— saves— reposts

Sentiment

Positive——Negative

Summary

Not enough discussion yet.

No sentiment analysis available yet.

Featured Source

Sentiment

Positive——Negative

Summary

Not enough discussion yet.

No sentiment analysis available yet.

3 Sources

Barron's@barronsonlineJohnson & Johnson Hikes Earnings Guidance but Pharma Growth Masks a MedTech Stumble https://www.barrons.com/articles/johnson-johnson-jnj-earnings-stock-price-c920b852?mod=bol-social-tw2h
CNBC@CNBCJ&J beats earnings estimates; Middle East conflict weighs on medical-device sales https://www.cnbc.com/2026/10/13/jnj-earnings-q3-2026.html?taid=6ace0eb2d9017d000112fac9&utm_campaign=trueanthem&utm_content=main&utm_medium=social&utm_source=twitter2h
Bloomberg@businessJohnson & Johnson raises its profit guidance, driven by demand for newer drugs in cancer and autoimmune diseases https://www.bloomberg.com/news/articles/2026-10-13/j-j-lifts-earnings-outlook-after-jump-in-quarterly-drug-sales?taid=6ace27d79334400001312871&utm_campaign=trueanthem&utm_content=business&utm_medium=social&utm_source=twitter14m
    • Home
    • Technology
    • Gaming
    • Entertainment
    • World & Business
    • Science
    • Sports
    • AI

    3 Sources

    Barron's@barronsonlineJohnson & Johnson Hikes Earnings Guidance but Pharma Growth Masks a MedTech Stumble https://www.barrons.com/articles/johnson-johnson-jnj-earnings-stock-price-c920b852?mod=bol-social-tw2h
    CNBC@CNBCJ&J beats earnings estimates; Middle East conflict weighs on medical-device sales https://www.cnbc.com/2026/10/13/jnj-earnings-q3-2026.html?taid=6ace0eb2d9017d000112fac9&utm_campaign=trueanthem&utm_content=main&utm_medium=social&utm_source=twitter2h
    Bloomberg@businessJohnson & Johnson raises its profit guidance, driven by demand for newer drugs in cancer and autoimmune diseases https://www.bloomberg.com/news/articles/2026-10-13/j-j-lifts-earnings-outlook-after-jump-in-quarterly-drug-sales?taid=6ace27d79334400001312871&utm_campaign=trueanthem&utm_content=business&utm_medium=social&utm_source=twitter14m
    Today's Rank

    #3

    Today's Rank

    #3